S&P Global set a €95.00 ($110.47) price objective on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report report published on Monday morning. The firm currently has a buy rating on the stock.

Several other research analysts have also recently issued reports on the stock. J P Morgan Chase & Co set a €95.10 ($110.58) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Thursday, September 14th. Goldman Sachs Group, Inc. (The) set a €97.00 ($112.79) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Tuesday, September 12th. Morgan Stanley set a €90.00 ($104.65) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Friday, September 15th. Deutsche Bank AG set a €83.00 ($96.51) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research note on Friday, October 20th. Finally, Berenberg Bank set a €95.60 ($111.16) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research note on Tuesday, September 19th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and ten have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of €89.28 ($103.81).

Shares of Fresenius Medical Care AG & Co. (FME) traded down €0.20 ($0.23) during trading on Monday, hitting €84.19 ($97.90). 602,664 shares of the stock traded hands, compared to its average volume of 554,980. Fresenius Medical Care AG & Co. has a fifty-two week low of €70.69 ($82.20) and a fifty-two week high of €89.22 ($103.74).

ILLEGAL ACTIVITY WARNING: “Fresenius Medical Care AG & Co. (Pref) (FME) Given a €95.00 Price Target at S&P Global” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/11/07/fresenius-medical-care-ag-95-00-price-target-at-sp-global.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Stock Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related stocks with our FREE daily email newsletter.